盐酸达泊西汀结构式
|
常用名 | 盐酸达泊西汀 | 英文名 | Dapoxetine Hydrochloride |
|---|---|---|---|---|
| CAS号 | 129938-20-1 | 分子量 | 341.874 | |
| 密度 | N/A | 沸点 | 454.4ºC at 760 mmHg | |
| 分子式 | C21H24ClNO | 熔点 | 175-179ºC | |
| MSDS | 中文版 美版 | 闪点 | 132.6ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
盐酸达泊西汀用途Dapoxetine盐酸盐短效的选择性5羟色胺重吸收抑制剂。 |
| 中文名 | 达泊西汀盐酸盐 |
|---|---|
| 英文名 | Dapoxetine Hydrochloride |
| 中文别名 | (S)-N,N-二甲基-α-[2-(1-萘氧基)乙基]苯甲胺盐酸盐 | 盐酸达泊西汀 | (S)-N,N-二甲基-3-(1-萘氧基)-1-苯丙胺盐酸盐 | 右旋达泊西汀盐酸盐 | 右旋达泊西汀 |
| 英文别名 | 更多 |
| 描述 | Dapoxetine盐酸盐短效的选择性5羟色胺重吸收抑制剂。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 沸点 | 454.4ºC at 760 mmHg |
|---|---|
| 熔点 | 175-179ºC |
| 分子式 | C21H24ClNO |
| 分子量 | 341.874 |
| 闪点 | 132.6ºC |
| 精确质量 | 341.154633 |
| PSA | 12.47000 |
| LogP | 5.71360 |
| 外观性状 | 白色至灰白色结晶固体 |
| 蒸汽压 | 1.27E-09mmHg at 25°C |
| 储存条件 | -20°C Freezer |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302-H319-H413 |
| 警示性声明 | P305 + P351 + P338 |
| 危害码 (欧洲) | Xn,N |
| 风险声明 (欧洲) | 22-36-50/53 |
| 安全声明 (欧洲) | 36-60-61 |
| 危险品运输编码 | UN 3077 9 / PGIII |
| 海关编码 | 2922199090 |
| 海关编码 | 2922199090 |
|---|---|
| 中文概述 | 2922199090. 其他氨基醇及其醚，酯和它们的盐（但含一种以上含氧基的除外）. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装 |
| Summary | 2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
New insights on premature ejaculation: a review of definition, classification, prevalence and treatment.
Asian J. Androl. 14(6) , 822-9, (2012) There are ongoing debates about the definition, classification and prevalence of premature ejaculation (PE). The first evidence-based definition of PE was limited to heterosexual men with lifelong PE ... |
|
|
Chiral recognition of dapoxetine enantiomers with methylated-gamma-cyclodextrin: a validated capillary electrophoresis method.
J. Pharm. Biomed. Anal. 62 , 42-7, (2012) The enantiomers of dapoxetine, a serotonin transporter inhibitor for the treatment of premature ejaculation have been separated by cyclodextrin modified capillary zone electrophoresis using uncoated f... |
|
|
Dapoxetine for premature ejaculation.
Expert Opin. Pharmacother. 11(10) , 1741-52, (2010) Premature ejaculation (PE) is a common male sexual disorder which is associated with substantial personal and interpersonal negative psychological factors. Drug treatment of PE with an off-label antid... |
| (1S)-N,N-Dimethyl-3-(1-naphthyloxy)-1-phenylpropan-1-amine hydrochloride (1:1) |
| (1S)-N,N-Dimethyl-3-(1-naphthyloxy)-1-phenyl-1-propanamine hydrochloride |
| ly 210448 hydrochloride |
| (S)-N,N-Dimethyl-α-[2-(1-naphthyloxy)ethyl]benzylamine Hydrochloride |
| (1S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride |
| (1S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-aminhydrochlorid |
| (1S)-N,N-Dimethyl-3-(1-naphthyloxy)-1-phenyl-1-propanamine hydrochloride (1:1) |
| Dapoxetine HCl |
| Benzenemethanamine, N,N-dimethyl-α-[2-(1-naphthalenyloxy)ethyl]-, (αS)-, hydrochloride (1:1) |
| (+)-(S)-N,N-Dimethyl-α-(2-(1-naphthyloxy)ethyl)benzylamine hydrochloride |
| (1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine,hydrochloride |
| MFCD08272809 |
| Benzenemethanamine, N,N-dimethyl-α-(2-(1-naphthalenyloxy)ethyl)-, hydrochloride, (αS)- |
| (S)-N,N-Dimethyl-3-(1-naphthyloxy)-1-phenylpropylamine Hydrochloride |
| (S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride |
查看所有供应商和价格请点击：